Chemical Compound

[7R-[3Z,5E,7R*,8S*,9S*,11E,13E,15S*,16R*(1S*,2R*,3S*,5E,7S*,8R*)]]-16-(2,8-Dihydroxy-1,3,7,9-tetramethyl-4-oxo-5-decenyl)-8-hydroxy-3,15-dimethoxy-5,7,9,11-tetramethyl-oxacyclohexadeca-3,5,11,13-tetraen-2-one; (3Z,5E,7R,8S,9S,11E,13E,15S,16R)-16-[(1S,2R,3S,5E,7S,8R)-2,8-Dihydroxy-1,3,7,9-tetramethyl-4-oxo-5-decen-1-yl]-8-hydroxy-3,15-dimethoxy-5,7,9,11-tetramethyloxacyclohexadeca-3,5,11,13-tetraen-2-one; Oxacyclohexadecane, hygrolidin deriv.; Bafilomycin D; Tubaymycin; 21-de[(3-Carboxy-1-oxo-2-propenyl)oxy]-19,23-deepoxy-20,21-didehydro-2-demethyl-19-deoxy-23-hydroxy-2-methoxy-24-methyl-19-oxo-hygrolidin

CAS Registry Number 98813-13-9
[7R-[3Z,5E,7R*,8S*,9S*,11E,13E,15S*,16R*(1S*,2R*,3S*,5E,7S*,8R*)]]-16-(2,8-Dihydroxy-1,3,7,9-tetramethyl-4-oxo-5-decenyl)-8-hydroxy-3,15-dimethoxy-5,7,9,11-tetramethyl-oxacyclohexadeca-3,5,11,13-tetraen-2-one; (3Z,5E,7R,8S,9S,11E,13E,15S,16R)-16-[(1S,2R,3S,5E,7S,8R)-2,8-Dihydroxy-1,3,7,9-tetramethyl-4-oxo-5-decen-1-yl]-8-hydroxy-3,15-dimethoxy-5,7,9,11-tetramethyloxacyclohexadeca-3,5,11,13-tetraen-2-one; Oxacyclohexadecane, hygrolidin deriv.; Bafilomycin D; Tubaymycin; 21-de[(3-Carboxy-1-oxo-2-propenyl)oxy]-19,23-deepoxy-20,21-didehydro-2-demethyl-19-deoxy-23-hydroxy-2-methoxy-24-methyl-19-oxo-hygrolidin 结构式
Primary record

[7R-[3Z,5E,7R*,8S*,9S*,11E,13E,15S*,16R*(1S*,2R*,3S*,5E,7S*,8R*)]]-16-(2,8-Dihydroxy-1,3,7,9-tetramethyl-4-oxo-5-decenyl)-8-hydroxy-3,15-dimethoxy-5,7,9,11-tetramethyl-oxacyclohexadeca-3,5,11,13-tetraen-2-one; (3Z,5E,7R,8S,9S,11E,13E,15S,16R)-16-[(1S,2R,3S,5E,7S,8R)-2,8-Dihydroxy-1,3,7,9-tetramethyl-4-oxo-5-decen-1-yl]-8-hydroxy-3,15-dimethoxy-5,7,9,11-tetramethyloxacyclohexadeca-3,5,11,13-tetraen-2-one; Oxacyclohexadecane, hygrolidin deriv.; Bafilomycin D; Tubaymycin; 21-de[(3-Carboxy-1-oxo-2-propenyl)oxy]-19,23-deepoxy-20,21-didehydro-2-demethyl-19-deoxy-23-hydroxy-2-methoxy-24-methyl-19-oxo-hygrolidin

库存
2,211 克
纯度
99.5 %
CAS
98813-13-9

化合物标识与属性

CAS
98813-13-9
PubChem CID
23757106
SMILES
C[C@H]1C/C(=C/C=C/[C@@H]([C@H](OC(=O)/C(=C/C(=C/[C@H]([C@H]1O)C)/C)/OC)[C@@H](C)[C@H]([C@H](C)C(=O)/C=C/[C@H](C)[C@@H](C(C)C)O)O)OC)/C
Canonical SMILES
CO/C1=C\C(C)=C\[C@@H](C)[C@@H](O)[C@@H](C)C/C(C)=C/C=C/[C@H](OC)[C@@H]([C@@H](C)[C@@H](O)[C@H](C)C(=O)/C=C/[C@H](C)[C@H](O)C(C)C)OC1=O

名称与同义词

  • Bafilomycin D
  • bafilomycinD
  • MEGxm0_000384
  • ACon0_000814
  • ACon1_001567
  • DTXSID301023438
  • ZINC255287244
  • C35-H56-O8
  • HY-108970
  • CS-0033828
  • J1.035.283E
  • 98813-13-9
  • (3Z,5E,7R,8S,9S,11E,13E,15S,16R)-16-[(2S,3R,4S,6E,8S,9R)-3,9-dihydroxy-4,8,10-trimethyl-5-oxoundec-6-en-2-yl]-8-hydroxy-3,15-dimethoxy-5,7,9,11-tetramethyl-1-oxacyclohexadeca-3,5,11,13-tetraen-2-one
  • (3Z,5E,7R,8S,9S,11E,13E,15S,16R)-3,15-Dimethoxy-5,7,9,11-tetramethyl-8-hydroxy-16-[(1S,2R,3S,5E,7S,8R)-1,3,7,9-tetramethyl-2,8-dihydroxy-4-oxo-5-decenyl]-1-oxacyclohexadeca-3,5,11,13-tetrene-2-one
  • [7R-[3Z,5E,7R*,8S*,9S*,11E,13E,15S*,16R*(1S*,2R*,3S*,5E,7S*,8R*)]]-16-(2,8-Dihydroxy-1,3,7,9-tetramethyl-4-oxo-5-decenyl)-8-hydroxy-3,15-dimethoxy-5,7,9,11-tetramethyl-oxacyclohexadeca-3,5,11,13-tetraen-2-one; (3Z,5E,7R,8S,9S,11E,13E,15S,16R)-16-[(1S,2R,3S,5E,7S,8R)-2,8-Dihydroxy-1,3,7,9-tetramethyl-4-oxo-5-decen-1-yl]-8-hydroxy-3,15-dimethoxy-5,7,9,11-tetramethyloxacyclohexadeca-3,5,11,13-tetraen-2-one; Oxacyclohexadecane, hygrolidin deriv.; Bafilomycin D; Tubaymycin; 21-de[(3-Carboxy-1-oxo-2-propenyl)oxy]-19,23-deepoxy-20,21-didehydro-2-demethyl-19-deoxy-23-hydroxy-2-methoxy-24-methyl-19-oxo-hygrolidin